Whole body 18fluoro-l-dopa PET-CT: A useful tool for location and surgical guidance in primary carcinoid tumours

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 35, Issue 8, 2008, Pages 1577-

  Arbizu, J ^a   Rodriguez Fraile, M ^a   Dominguez Prado, I ^a   Garrastachu, P ^a   Rotellar, F ^a   Sangro, B ^a   Richter, J A ^a  

^a Instituto de Investigación Sanitaria de Navarra   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; LEVODOPA; LEVODOPA F 18; PENTETREOTIDE IN 111; RADIOPHARMACEUTICAL AGENT; SEROTONIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER SURGERY; CARCINOID; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FLUSHING; HISTOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; SEROTONIN BLOOD LEVEL; ULTRASOUND; WHOLE BODY SCINTISCANNING;

ADOLESCENT; DIHYDROXYPHENYLALANINE; FEMALE; HUMANS; NEUROENDOCRINE TUMORS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SUBTRACTION TECHNIQUE; SURGERY, COMPUTER-ASSISTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 48149106508     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-008-0801-6     Document Type: Article

References (4)

1. IM Modlin K Oberg DC Chung RT Jensen WW de Herder RV Thakker 2008 Gastroenteropancreatic neuroendocrine tumours Lancet Oncol 9 61 72
2. KP Koopmans EG de Vries IP Kema PH Elsinga OC Neels WJ Sluiter 2006 Staging of carcinoid tumours with 18F-DOPA PET: a prospective, diagnostic accuracy study Lancet Oncol 7 728 734
3. V Ambrosini P Tomassetti D Rubello D Campana C Nanni P Castellucci 2007 Role of 18F-dopa PET/CT imaging in the management of patients with 111In-pentetreotide negative GEP tumours Nucl Med Commun 28 473 477
4. AG Pearse 1974 The APUD cell concept and its implications in pathology Pathol Annu 9 27 41